Sophos selects top performer to lead North American sales growth

Sophos Press Release

Anti-virus leader names Mark Hatton Vice President of Sales of North American operations


Lynnfield, MA - Sophos, a world leader in corporate anti-virus solutions, today announced the appointment of senior executive, Mark Hatton to vice president of North American sales. Mark assumes his position today.

"North America plays a key role in Sophos's overall revenue target," said Mark Forrest, director of global sales and marketing. "We selected Mark Hatton because he possesses strong leadership qualities and is well-versed in helping organizations achieve and surpass revenue objectives."

Hatton has held numerous leadership roles throughout his 14-year career where he has developed diverse general management, sales and operations experience with companies ranging from venture capital backed early stage software companies to a Fortune 500 information technology services and distribution company. Most recently, Hatton was vice president, worldwide sales at Tilion, Inc. There he developed and implemented a sales team, compensation plans, strategic sales plan, as well as product positioning.

"Sophos has an amazing reputation in the anti-virus industry worldwide," said Mark Hatton, vice president of North American sales at Sophos. "The company has continuously upheld its values by producing first-class products, backed with exceptional customer service, which has helped maintain its loyal, steadily growing client-base. I look forward to contributing to Sophos's profitability and growth."

Hatton earned a bachelor's degree from Westfield State College.

More than 100 million users in 150 countries rely on Sophos’ complete security solutions as the best protection against complex threats and data loss. Simple to deploy, manage, and use, Sophos’ award-winning encryption, endpoint security, web, email, mobile and network security solutions are backed by SophosLabs - a global network of threat intelligence centers. Sophos is headquartered in Oxford, U.K., and is publicly traded on the London Stock Exchange under the symbol “SOPH.” More information is available at